Spectrum Pharmaceuticals, Inc. SPPI announced that it has added two new cohorts in the phase II study — ZENITH20. The study is evaluating its pipeline candidate, poziotinib, in non-small cell lung ...

Europe’s mobile operators could unlock billions in potential infrastructure investment, accelerating 5G standalone (5G SA) ...

Spectrum Pharmaceuticals, Inc. SPPI announced positive data from a phase III study, ADVANCE, evaluating its lead pipeline candidate, Rolontis, for management of chemotherapy-induced neutropenia in ...

Widely accepted projections of a shortage of mobile spectrum may not be as dire as many analysts in the mobile and tech sectors are making it out to be, according to a new study. Projections on the ...

Narrow-spectrum antibiotics are preferable to broad-spectrum antibiotics for treating most children with acute respiratory tract infections, according to a pair of studies published in JAMA. The ...

Shares of Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) saw a handy gain early on Tuesday after the firm provided an update on its midstage non-small cell lung cancer (NSCLC) study. Specifically, the ...

The Middle Class Tax Relief and Job Creation Act of 2012 (the same law that allowed incentive auction of TV spectrum) required the General Accounting Office to conduct a study of spectrum efficiency, ...

The FAA is part of a multi-agency team that has received approval from the Office of Management and Budget (OMB) for approximately $71.5 million in funding to proceed with an effort to study the ...

2 July, 2020 - WASHINGTON, USA: The U.S. needs to expand its 5G spectrum pipeline and license the lower 3 GHz band for commercial use in order to keep pace with other countries that are moving ...